{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T01:50:06Z","timestamp":1783734606566,"version":"3.55.0"},"reference-count":74,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000069","name":"NIH\/NIAMS","doi-asserted-by":"publisher","award":["AR042220"],"award-info":[{"award-number":["AR042220"]}],"id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000069","name":"NIH\/NIAMS","doi-asserted-by":"publisher","award":["AR42271"],"award-info":[{"award-number":["AR42271"]}],"id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice &amp; Research Clinical Obstetrics &amp; Gynaecology"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1016\/j.bpobgyn.2019.09.001","type":"journal-article","created":{"date-parts":[[2019,10,8]],"date-time":"2019-10-08T01:39:59Z","timestamp":1570498799000},"page":"41-51","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":70,"special_numbering":"C","title":["Autoimmune-mediated congenital heart block"],"prefix":"10.1016","volume":"64","author":[{"given":"Benjamin","family":"Wainwright","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rohit","family":"Bhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Trad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amit","family":"Saxena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jill","family":"Buyon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Izmirly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bpobgyn.2019.09.001_bib1","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1161\/CIRCULATIONAHA.111.033894","article-title":"Maternal and fetal factors associated with mortality and morbidity in a multi-racial\/ethnic registry of anti-SSA\/Ro-associated cardiac neonatal lupus","volume":"124","author":"Izmirly","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.bpobgyn.2019.09.001_bib2","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1067\/mpd.2003.233","article-title":"Incidence and spectrum of neonatal lupus erythematosus: a prospective study of infants born to mothers with anti-Ro autoantibodies","volume":"142","author":"Cimaz","year":"2003","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.bpobgyn.2019.09.001_bib3","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1067\/mpd.2000.109108","article-title":"Cutaneous manifestations of neonatal lupus without heart block: characteristics of mothers and children enrolled in a national registry","volume":"137","author":"Neiman","year":"2000","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.bpobgyn.2019.09.001_bib4","doi-asserted-by":"crossref","first-page":"E11","DOI":"10.1542\/peds.109.1.e11","article-title":"Hepatobiliary disease in neonatal lupus: prevalence and clinical characteristics in cases enrolled in a national registry","volume":"109","author":"Lee","year":"2002","journal-title":"Pediatrics"},{"key":"10.1016\/j.bpobgyn.2019.09.001_bib5","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1177\/0961203309354542","article-title":"Frequency of neuro-psychiatric dysfunction in anti-SSA\/SSB exposed children with and without neonatal lupus","volume":"19","author":"Askanase","year":"2010","journal-title":"Lupus"},{"key":"10.1016\/j.bpobgyn.2019.09.001_bib6","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s12016-009-8190-6","article-title":"Pregnancy outcomes in patients with autoimmune diseases and anti-Ro\/SSA antibodies","volume":"40","author":"Brucato","year":"2011","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.bpobgyn.2019.09.001_bib7","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/0002-9149(86)90064-0","article-title":"Anatomy of congenital complete heart block and relation to maternal anti-Ro antibodies","volume":"58","author":"Ho","year":"1986","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.bpobgyn.2019.09.001_bib8","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1186\/ar763","article-title":"From antibody insult to fibrosis in neonatal lupus - the heart of the matter","volume":"5","author":"Buyon","year":"2003","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.bpobgyn.2019.09.001_bib9","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1093\/rheumatology\/ker515","article-title":"Anatomical and pathological findings in hearts from fetuses and infants with cardiac manifestations of neonatal lupus","volume":"51","author":"Llanos","year":"2012","journal-title":"Rheumatology"},{"key":"10.1016\/j.bpobgyn.2019.09.001_bib10","first-page":"36","article-title":"A\u00a0review of congenital heart block","volume":"5","author":"Friedman","year":"2003","journal-title":"Images Paediatr Cardiol"},{"key":"10.1016\/j.bpobgyn.2019.09.001_bib11","first-page":"1862","article-title":"The increasing incidence of isolated congenital heart block in Finland","volume":"25","author":"Siren","year":"1998","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.bpobgyn.2019.09.001_bib12","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1111\/aogs.12785","article-title":"Outcome in 212 anti-Ro\/SSA-positive pregnancies and population-based incidence of congenital heart block","volume":"95","author":"Skog","year":"2016","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.bpobgyn.2019.09.001_bib13","doi-asserted-by":"crossref","first-page":"3187","DOI":"10.1002\/art.20554","article-title":"Outcome of pregnancies in patients with anti-SSA\/Ro antibodies: a study of 165 pregnancies, with special focus on electrocardiographic variations in the children and comparison with a control group","volume":"50","author":"Costedoat-Chalumeau","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.bpobgyn.2019.09.001_bib14","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1002\/1529-0131(200108)44:8<1832::AID-ART320>3.0.CO;2-C","article-title":"Risk of congenital complete heart block in newborns of mothers with anti-Ro\/SSA antibodies detected by counterimmunoelectrophoresis: a prospective study of 100 women","volume":"44","author":"Brucato","year":"2001","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.bpobgyn.2019.09.001_bib15","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1161\/CIRCULATIONAHA.107.707661","article-title":"Utility of cardiac monitoring in fetuses at risk for congenital heart block: the PR Interval and Dexamethasone Evaluation (PRIDE) prospective study","volume":"117","author":"Friedman","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.bpobgyn.2019.09.001_bib16","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1016\/S0735-1097(98)00161-2","article-title":"Autoimmune-associated congenital heart block: demographics, mortality, morbidity and recurrence rates obtained from a national neonatal lupus registry","volume":"31","author":"Buyon","year":"1998","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.bpobgyn.2019.09.001_bib17","doi-asserted-by":"crossref","first-page":"3091","DOI":"10.1002\/art.24768","article-title":"Recurrence rates of cardiac manifestations associated with neonatal lupus and maternal\/fetal risk factors","volume":"60","author":"Llanos","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.bpobgyn.2019.09.001_bib18","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1056\/NEJM197712012972203","article-title":"Association of maternal systemic lupus erythematosus with congenital complete heart block","volume":"297","author":"Chameides","year":"1977","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.bpobgyn.2019.09.001_bib19","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1136\/adc.41.220.688","article-title":"Congenital heart block and widespread fibrosis due to maternal lupus erythematosus","volume":"41","author":"Hull","year":"1966","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.bpobgyn.2019.09.001_bib20","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1038\/nrrheum.2015.29","article-title":"The clinical spectrum of autoimmune congenital heart block","volume":"11","author":"Brito-Zeron","year":"2015","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.bpobgyn.2019.09.001_bib21","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1136\/ard.2008.088054","article-title":"Disease progression in mothers of children enrolled in the research registry for neonatal lupus","volume":"68","author":"Rivera","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.bpobgyn.2019.09.001_bib22","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/0090-1229(85)90045-5","article-title":"Antinuclear, anticytoplasmic, and anti-Sjogren's syndrome antigen A (SS-A\/Ro) antibodies in female blood donors","volume":"36","author":"Fritzler","year":"1985","journal-title":"Clin Immunol Immunopathol"},{"key":"10.1016\/j.bpobgyn.2019.09.001_bib23","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1002\/art.34380","article-title":"Prevalence and sociodemographic correlates of antinuclear antibodies in the United States","volume":"64","author":"Satoh","year":"2012","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.bpobgyn.2019.09.001_bib24","series-title":"Systemic lupus erythematosus","first-page":"259","article-title":"Extractable nuclear antigens and SLE: specificity and role in disease pathogenesis","author":"Keogan","year":"2011"},{"key":"10.1016\/j.bpobgyn.2019.09.001_bib25","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1016\/j.autrev.2017.07.013","article-title":"Clinical and pathologic implications of extending the spectrum of maternal autoantibodies reactive with ribonucleoproteins associated with cutaneous and now cardiac neonatal lupus from SSA\/Ro and SSB\/La to U1RNP","volume":"16","author":"Izmirly","year":"2017","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.bpobgyn.2019.09.001_bib26","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1136\/annrheumdis-2011-200414","article-title":"Anti-Ro52 monoclonal antibodies specific for amino acid 200-239, but not other Ro52 epitopes, induce congenital heart block in a rat model","volume":"71","author":"Ambrosi","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.bpobgyn.2019.09.001_bib27","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1016\/j.autrev.2013.04.006","article-title":"Preventing congenital neonatal heart block in offspring of mothers with anti-SSA\/Ro and SSB\/La antibodies: a review of published literature and registered clinical trials","volume":"12","author":"Gleicher","year":"2013","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.bpobgyn.2019.09.001_bib28","doi-asserted-by":"crossref","first-page":"2782","DOI":"10.1002\/1521-4141(200010)30:10<2782::AID-IMMU2782>3.0.CO;2-9","article-title":"Anti-SSA\/Ro52 autoantibodies blocking the cardiac 5-HT4 serotoninergic receptor could explain neonatal lupus congenital heart block","volume":"30","author":"Eftekhari","year":"2000","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.bpobgyn.2019.09.001_bib29","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/j.1365-2249.2008.03732.x","article-title":"Antibodies to amino acid 200-239 (p200) of Ro52 as serological markers for the risk of developing congenital heart block","volume":"154","author":"Strandberg","year":"2008","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.bpobgyn.2019.09.001_bib30","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1002\/acr.21704","article-title":"Umbilical cord blood levels of maternal antibodies reactive with p200 and full-length Ro 52 in the assessment of risk for cardiac manifestations of neonatal lupus","volume":"64","author":"Reed","year":"2012","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.bpobgyn.2019.09.001_bib31","doi-asserted-by":"crossref","first-page":"2778","DOI":"10.1016\/j.jacc.2010.02.042","article-title":"The importance of the level of maternal anti-Ro\/SSA antibodies as a prognostic marker of the development of cardiac neonatal lupus erythematosus a prospective study of 186 antibody-exposed fetuses and infants","volume":"55","author":"Jaeggi","year":"2010","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"11","key":"10.1016\/j.bpobgyn.2019.09.001_bib32","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.1093\/rheumatology\/kez141","article-title":"Pregnancy outcomes in mixed connective tissue disease: a multicentre study","volume":"58","author":"Radin","year":"2019","journal-title":"Rheumatol (Oxf)"},{"key":"10.1016\/j.bpobgyn.2019.09.001_bib33","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1002\/art.1780400223","article-title":"Monozygotic twins discordant for congenital complete heart block","volume":"40","author":"Cooley","year":"1997","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.bpobgyn.2019.09.001_bib34","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.4049\/jimmunol.0902248","article-title":"Ro60-associated single-stranded RNA links inflammation with fetal cardiac fibrosis via ligation of TLRs: a novel pathway to autoimmune-associated heart block","volume":"184","author":"Clancy","year":"2010","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.bpobgyn.2019.09.001_bib35","first-page":"2413","article-title":"Impaired clearance of apoptotic cardiocytes is linked to anti-SSA\/Ro and -SSB\/La antibodies in the pathogenesis of congenital heart block","volume":"116","author":"Clancy","year":"2006","journal-title":"J\u00a0Clin Investig"},{"key":"10.1016\/j.bpobgyn.2019.09.001_bib36","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1002\/art.11430","article-title":"Immunohistologic evidence supports apoptosis, IgG deposition, and novel macrophage\/fibroblast crosstalk in the pathologic cascade leading to congenital heart block","volume":"50","author":"Clancy","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.bpobgyn.2019.09.001_bib37","doi-asserted-by":"crossref","first-page":"5345","DOI":"10.4049\/jimmunol.165.9.5345","article-title":"Anti-SSA\/Ro and anti-SSB\/La autoantibodies bind the surface of apoptotic fetal cardiocytes and promote secretion of TNF-alpha by macrophages","volume":"165","author":"Miranda-Carus","year":"2000","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.bpobgyn.2019.09.001_bib38","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1161\/01.CIR.103.11.1599","article-title":"Direct inhibition of expressed cardiac l- and t-type calcium channels by IgG from mothers whose children have congenital heart block","volume":"103","author":"Xiao","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.bpobgyn.2019.09.001_bib39","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1111\/j.1540-8167.2011.02032.x","article-title":"Rescue and worsening of congenital heart block-associated electrocardiographic abnormalities in two transgenic mice","volume":"22","author":"Karnabi","year":"2011","journal-title":"J\u00a0Cardiovasc Electrophysiol"},{"key":"10.1016\/j.bpobgyn.2019.09.001_bib40","doi-asserted-by":"crossref","first-page":"520","DOI":"10.4049\/jimmunol.1100122","article-title":"beta2-glycoprotein I and protection from anti-SSA\/Ro60-associated cardiac manifestations of neonatal lupus","volume":"187","author":"Reed","year":"2011","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.bpobgyn.2019.09.001_bib41","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1016\/j.jacc.2015.06.1088","article-title":"Serum biomarkers of inflammation, fibrosis, and cardiac function in facilitating diagnosis, prognosis, and treatment of anti-SSA\/ro-associated cardiac neonatal lupus","volume":"66","author":"Saxena","year":"2015","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.bpobgyn.2019.09.001_bib42","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/gene.2009.20","article-title":"Peripheral blood gene expression profiling in Sjogren's syndrome","volume":"10","author":"Emamian","year":"2009","journal-title":"Genes Immun"},{"key":"10.1016\/j.bpobgyn.2019.09.001_bib43","doi-asserted-by":"crossref","first-page":"2610","DOI":"10.1073\/pnas.0337679100","article-title":"Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus","volume":"100","author":"Baechler","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.bpobgyn.2019.09.001_bib44","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1136\/annrheumdis-2016-210927","article-title":"High maternal expression of SIGLEC1 on monocytes as a surrogate marker of a type I interferon signature is a risk factor for the development of autoimmune congenital heart block","volume":"76","author":"Lisney","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.bpobgyn.2019.09.001_bib45","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1002\/art.23404","article-title":"Sialic acid-binding Ig-like lectin 1 expression in inflammatory and resident monocytes is a potential biomarker for monitoring disease activity and success of therapy in systemic lupus erythematosus","volume":"58","author":"Biesen","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.bpobgyn.2019.09.001_bib46","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1002\/art.22382","article-title":"A\u00a0macrophage marker, Siglec-1, is increased on circulating monocytes in patients with systemic sclerosis and induced by type I interferons and toll-like receptor agonists","volume":"56","author":"York","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.bpobgyn.2019.09.001_bib47","doi-asserted-by":"crossref","first-page":"48","DOI":"10.4049\/jimmunol.1800357","article-title":"Siglec-1 macrophages and the contribution of IFN to the development of autoimmune congenital heart block","volume":"202","author":"Clancy","year":"2019","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.bpobgyn.2019.09.001_bib48","doi-asserted-by":"crossref","first-page":"3253","DOI":"10.4049\/jimmunol.171.6.3253","article-title":"Cytokine polymorphisms and histologic expression in autopsy studies: contribution of TNF-alpha and TGF-beta 1 to the pathogenesis of autoimmune-associated congenital heart block","volume":"171","author":"Clancy","year":"2003","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.bpobgyn.2019.09.001_bib49","doi-asserted-by":"crossref","first-page":"3415","DOI":"10.1002\/art.27658","article-title":"Identification of candidate loci at 6p21 and 21q22 in a genome-wide association study of cardiac manifestations of neonatal lupus","volume":"62","author":"Clancy","year":"2010","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.bpobgyn.2019.09.001_bib50","doi-asserted-by":"crossref","first-page":"2170","DOI":"10.1002\/art.40228","article-title":"Association of natural killer cell ligand polymorphism HLA-C Asn80Lys with the development of anti-SSA\/ro-associated congenital heart block","volume":"69","author":"Ainsworth","year":"2017","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.bpobgyn.2019.09.001_bib51","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1016\/j.jacc.2010.12.014","article-title":"Prolongation of the atrioventricular conduction in fetuses exposed to maternal anti-Ro\/SSA and anti-La\/SSB antibodies did not predict progressive heart block. A prospective observational study on the effects of maternal antibodies on 165 fetuses","volume":"57","author":"Jaeggi","year":"2011","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.bpobgyn.2019.09.001_bib52","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1191\/0961203302lu173oa","article-title":"Spectrum and progression of conduction abnormalities in infants born to mothers with anti-SSA\/Ro-SSB\/La antibodies","volume":"11","author":"Askanase","year":"2002","journal-title":"Lupus"},{"key":"10.1016\/j.bpobgyn.2019.09.001_bib53","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.ijcard.2017.07.100","article-title":"Incidence, risk factors, and mortality of neonatal and late-onset dilated cardiomyopathy associated with cardiac neonatal lupus","volume":"248","author":"Morel","year":"2017","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.bpobgyn.2019.09.001_bib54","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/j.amjcard.2010.10.059","article-title":"Spontaneous rupture of atrioventricular valve tensor apparatus as late manifestation of anti-Ro\/SSA antibody-mediated cardiac disease","volume":"107","author":"Cuneo","year":"2011","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.bpobgyn.2019.09.001_bib55","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/S0735-1097(00)01048-2","article-title":"Congenital heart block: development of late-onset cardiomyopathy, a previously underappreciated sequela","volume":"37","author":"Moak","year":"2001","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.bpobgyn.2019.09.001_bib56","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1097\/CRD.0b013e31823c808b","article-title":"Cardiac manifestations of neonatal lupus: a review of autoantibody-associated congenital heart block and its impact in an adult population","volume":"20","author":"Capone","year":"2012","journal-title":"Cardiol Rev"},{"key":"10.1016\/j.bpobgyn.2019.09.001_bib57","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1136\/annrheumdis-2018-214406","article-title":"Comorbidity and long-term outcome in patients with congenital heart block and their siblings exposed to Ro\/SSA autoantibodies in utero","volume":"78","author":"Mofors","year":"2019","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.bpobgyn.2019.09.001_bib58","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1161\/01.CIR.0000142046.58632.3A","article-title":"Transplacental fetal treatment improves the outcome of prenatally diagnosed complete atrioventricular block without structural heart disease","volume":"110","author":"Jaeggi","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.bpobgyn.2019.09.001_bib59","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1136\/annrheumdis-2015-208311","article-title":"Assessment of fluorinated steroids to avert progression and mortality in anti-SSA\/Ro-associated cardiac injury limited to the fetal conduction system","volume":"75","author":"Izmirly","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.bpobgyn.2019.09.001_bib60","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.ijcard.2016.09.119","article-title":"Fluorinated steroids do not improve outcome of isolated atrioventricular block","volume":"225","author":"Van den Berg","year":"2016","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.bpobgyn.2019.09.001_bib61","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1016\/j.autrev.2015.08.005","article-title":"Description of 214 cases of autoimmune congenital heart block: results of the French neonatal lupus syndrome","volume":"14","author":"Levesque","year":"2015","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.bpobgyn.2019.09.001_bib62","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/j.autrev.2017.09.005","article-title":"Should we treat congenital heart block with fluorinated corticosteroids?","volume":"16","author":"Brucato","year":"2017","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.bpobgyn.2019.09.001_bib63","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/j.jacc.2010.09.044","article-title":"Use of intravenous gamma globulin and corticosteroids in the treatment of maternal autoantibody-mediated cardiomyopathy","volume":"57","author":"Trucco","year":"2011","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.bpobgyn.2019.09.001_bib64","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1136\/ard.2009.119263","article-title":"Evaluation of the risk of anti-SSA\/Ro-SSB\/La antibody-associated cardiac manifestations of neonatal lupus in fetuses of mothers with systemic lupus erythematosus exposed to hydroxychloroquine","volume":"69","author":"Izmirly","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.bpobgyn.2019.09.001_bib65","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1161\/CIRCULATIONAHA.111.089268","article-title":"Maternal use of hydroxychloroquine is associated with a reduced risk of recurrent anti-SSA\/Ro-antibody-associated cardiac manifestations of neonatal lupus","volume":"126","author":"Izmirly","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.bpobgyn.2019.09.001_bib66","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1007\/s12026-016-8888-5","article-title":"Obstetric and perinatal outcome in anti-Ro\/SSA-positive pregnant women: a prospective cohort study","volume":"65","author":"Martinez-Sanchez","year":"2017","journal-title":"Immunol Res"},{"key":"10.1016\/j.bpobgyn.2019.09.001_bib67","article-title":"Effect of in utero hydroxychloroquine exposure on the development of cutaneous neonatal lupus erythematosus","volume":"*","author":"Barsalou","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.bpobgyn.2019.09.001_bib68","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0950-3579(05)80244-4","article-title":"Maternal autoantibodies and pregnancy-II: the neonatal lupus syndrome","volume":"4","author":"Lee","year":"1990","journal-title":"Bailliere\u2019s Clin Rheumatol"},{"key":"10.1016\/j.bpobgyn.2019.09.001_bib69","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1002\/art.27333","article-title":"Cutaneous manifestations of neonatal lupus and risk of subsequent congenital heart block","volume":"62","author":"Izmirly","year":"2010","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.bpobgyn.2019.09.001_bib70","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.ajog.2016.07.002","article-title":"Detection and successful treatment of emergent anti-SSA-mediated fetal atrioventricular block","volume":"215","author":"Cuneo","year":"2016","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.bpobgyn.2019.09.001_bib71","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1002\/pd.5021","article-title":"Serial echocardiography for immune-mediated heart disease in the fetus: results of a risk-based prospective surveillance strategy","volume":"37","author":"Kan","year":"2017","journal-title":"Prenat Diagn"},{"key":"10.1016\/j.bpobgyn.2019.09.001_bib72","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1016\/j.jacc.2018.07.076","article-title":"Home monitoring for fetal heart rhythm during anti-ro pregnancies","volume":"72","author":"Cuneo","year":"2018","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"1","key":"10.1016\/j.bpobgyn.2019.09.001_bib73","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.ajog.2012.09.020","article-title":"Maternal autoantibody levels in congenital heart block and potential prophylaxis with antiinflammatory agents","volume":"208","author":"Tunks","year":"2013","journal-title":"Am J Obstet Gynecol"},{"issue":"9","key":"10.1016\/j.bpobgyn.2019.09.001_bib74","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1093\/rheumatology\/kex191","article-title":"Prenatal exposure to antimalarials decreases the risk of cardiac but not non-cardiac neonatal lupus: a single-centre cohort study","volume":"56","author":"Barsalou","year":"2017","journal-title":"Rheumatology (Oxford)"}],"container-title":["Best Practice &amp; Research Clinical Obstetrics &amp; Gynaecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521693419301324?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521693419301324?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T17:10:37Z","timestamp":1761498637000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521693419301324"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4]]},"references-count":74,"alternative-id":["S1521693419301324"],"URL":"https:\/\/doi.org\/10.1016\/j.bpobgyn.2019.09.001","relation":{},"ISSN":["1521-6934"],"issn-type":[{"value":"1521-6934","type":"print"}],"subject":[],"published":{"date-parts":[[2020,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Autoimmune-mediated congenital heart block","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Obstetrics & Gynaecology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bpobgyn.2019.09.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}